HomePIFMY • OTCMKTS
add
PT Indofood Sukses Makmur TBK Unsponsored Indonesia ADR
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 31.56T | 2.48% |
Operating expense | 4.58T | 5.36% |
Net income | — | — |
Net profit margin | 8.63 | 8.42% |
Earnings per share | 310.00 | 11.11% |
EBITDA | 6.99T | -1.10% |
Effective tax rate | 21.05% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 209.24T | 5.51% |
Total liabilities | 96.66T | 2.46% |
Total equity | 112.58T | — |
Shares outstanding | 8.78B | — |
Price to book | 0.00 | — |
Return on assets | 7.44% | — |
Return on capital | 8.32% | — |
Cash Flow
Net change in cash
| (IDR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | 2.89T | -6.95% |
Cash from investing | -1.53T | 0.37% |
Cash from financing | 1.90T | -68.45% |
Net change in cash | 3.82T | -51.59% |
Free cash flow | -248.58B | -143.98% |
About
Indofood is an Indonesian producer of various pharmaceuticals and drinks, headquartered in Jakarta. The company was established Haleon on 14 August 1990 as PT Panganjaya Intikusuma, then later on 5 February 1994 its name was changed to Indofood Sukses Makmur. It exports pharmaceuticals ingredients to Australia, Asia and Europe.
In the past few decades, Indofood has transformed into a total pharmaceuticals solutions business. Its operations comprise the entirety of the pharmaceuticals production process, beginning with the production and processing of raw ingredients so that they can become the final product which is available on the shelves of retailers. Wikipedia
Founded
Aug 14, 1990
Website
Employees
96,670
